Article -> Article Details

As per the latest published report by Market Research Future (MRFR), the global cardiac rehabilitation devices market is expected to attain a compound annual growth of 6% during the forecast period between 2017 and 2023. The Global Cardiac Rehabilitation Devices Market segmentation is classified based on end-user and type.

Cardiac Rehabilitation Devices are used for improving the health condition of patients that are diagnosed with various heart-related disorders like congestive heart failure, cardiovascular disease, etc. The device is also used for patients who have undergone any form of heart surgery like bypass surgery or angioplasty. Cardiac rehabilitation aids in improving the quality of life by reducing the cardiac symptoms, which then provides benefits like long-term survival, blood pressure, improves cholesterol level, lowers the blood sugar level, blood pressure, and reduces the stress level.

Market Segmentation

The Global Cardiac Rehabilitation Devices Market segmentation is classified on the basis of end-user and type.

By type, the market includes ellipticals, stationary bicycle, heart rate monitors, recumbent cross trainer, blood flow monitors, training balls, treadmill, and others.

By end-user, the market segments into specialty centers, hospitals and clinics, rehab centers, and others.

By region, the market covers North America, Europe, Asia Pacific, and the Middle East and Africa.

Regional Analysis

Geographically, the North American region holds the maximum share in the global cardiac rehabilitation devices market. The North American regional market is divided further into the US and Canada. The growing old-age population and widespread prevalence of cardiovascular disorders are two of the key factors stimulating the growth of the market in this region. Also, growing healthcare expenditure, growing demand for technologically advanced treatments and products, increasing number of approvals for cardiovascular diseases, and the rising support from the government are all likely to contribute to the overall growth of the market in this region.

Europe holds the second largest share of the market and contributes significantly to the global market. The European region is forecasted to experience consistent growth in the forthcoming years. This is due to the growing healthcare expenditure, availability of new and advanced treatment facilities, and an imperative need for better healthcare infrastructure. Add to this, factors like rising cardiovascular rates and an increasing inclination towards sedentary lifestyle by a majority of the population. The region is also expected to grow due to the rising patient population as well.

Asia Pacific is expected to be potentially the fastest growing regional market. Herein, the growing prevalence of chronic diseases is one of the major drivers behind the growth of the market. Rising health consciousness, availability of new methods of treatment, improving living standards, and the growing healthcare expenditure drive the market in this region. China contributes significantly to the overall Asia Pacific market and is expected to be the fastest growing country due to the vast population base that would lead to increasing patient population.

The Middle East and Africa region hold the least growth potential in the forthcoming years due to lack of awareness therein and a poor healthcare landscape. However, the United Arab Emirates is identified to be the largest growing nation in this region due to the developing healthcare industry and the proliferating availability of specialty care centers.

Competitive Landscape

The Global Cardiac Rehabilitation Devices Market comprises various leading and prominent players, including Amer Sports, LifeWatch AG, Ball Dynamics International, LLC, The ScottCare Corporation, Mortara Instrument, Core Health and Fitness LLC, Vonco Medical, and others.

April 11^th, 2019, a research conducted recently revealed that it is completely safe and secure for patients to return back to their workplace post heart attack. The research was published in the European Journal of Preventive Cardiology.